News

Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by 11.76 ...
Jim Cramer on Hims & Hers: “You Gotta Generate Some Discipline Here”
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 14 stocks Jim Cramer recently shared insights on. Discussing the ...
Massive News for Hims & Hers Stock Investors!
Hims & Hers' (NYSE: HIMS) stock crashed over 30% following news highlighting the end of its relationship with Novo Nordisk ...
TMCnet5h
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
On April 29, 2025, Hims announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of "a bundled offering of Novo Nordisk's FDA-approved Wegovy on the Hims & Hers platform ...
2 Volatile Stocks Worth Your Attention and 1 to Turn Down
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some ...
This Weight Loss Partnership Was a Short One
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Zacks.com on MSN4h
Barclays vs. HSBC: Which Global Bank is the Smarter Buy Today?
Detailed price information for Barclays Plc ADR (BCS-N) from The Globe and Mail including charting and trades.